NCT05431010

Brief Summary

Introduction: The efficacy of existing therapies for the treatment of sarcopenia is still not satisfactory. Therefore, this randomized controlled, assessor-blinded study was designed to investigate the efficacy and safety of electroacupuncture(EA) therapy in elderly patients with sarcopenia. Methods and analysis: This randomized controlled trial will enroll 120 elderly patients with sarcopenia. Subjects will be randomly assigned in a 1:1 ratio to either EA combined with rehabilitation training group or rehabilitation training group through a central computerized randomization system. Primary outcome measure is lower limb mobility, including 6-minute walk test、timed get up and go test, and short physical performance battery. Secondary outcome measures include lower limb muscle mass and lower limb muscle strength. Outcome assessment will be conducted before the intervention, at 12 weeks after the intervention and at the end of the 12-week follow-up. Adverse reactions will be evaluated during the trial. Conclusion: This research will provide evidence to clarify whether EA is effective and safe in the treatment of sarcopenia.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P50-P75 for not_applicable

Timeline
8mo left

Started Jul 2022

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress86%
Jul 2022Dec 2026

First Submitted

Initial submission to the registry

June 12, 2022

Completed
12 days until next milestone

First Posted

Study publicly available on registry

June 24, 2022

Completed
8 days until next milestone

Study Start

First participant enrolled

July 2, 2022

Completed
3.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2025

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2026

Expected
Last Updated

February 24, 2026

Status Verified

February 1, 2026

Enrollment Period

3.5 years

First QC Date

June 12, 2022

Last Update Submit

February 22, 2026

Conditions

Keywords

sarcopenia;electroacupuncture; geriatric

Outcome Measures

Primary Outcomes (3)

  • 6min walk test

    The 6-min walking test setup is a straight line of 20 meters on a flat floor, and a chair is placed at each end as a sign. The subjects walk back and forth between them. The pace of walking is determined according to their own physical fitness, and they walk as fast as possible. In this way, the maximum walking distance that an individual can reach within 6 minutes will be texted

    12 weeks

  • time to get up and go(TGUG)

    The TGUG test measures the time it takes for an individual to get up from a chair, complete a short 3 meters round-trip walk, and finally sit back in the chair.

    12 weeks

  • short physical performance battery (SPPB)

    SPPB is a comprehensive test instrument that includes a walking speed test, a sit-to-stand test, and a balance test. The Walking Speed Test measures the time to pass a distance of 4 meters at daily walking speed. Sit-to-stand test is to calculate the time to complete 5 consecutive sets of getting up-sit down. The balance test includes 3 parts: 10 seconds for standing on the left and right side of both feet; standing on half front and half rear feet and standing on front and rear feet

    12 weeks

Secondary Outcomes (5)

  • lower extremity skeletal muscle mass

    12 weeks

  • appendicular skeletal muscle mass(ASMM)

    12 weeks

  • calf circumference

    12 weeks

  • knee flexion and extension strength

    12 weeks

  • grip strength

    12 weeks

Study Arms (2)

electroacupuncture and rehabilitation training

EXPERIMENTAL

Participants in this group will received electroacupuncture(EA) combined with Otago exercise program(OEP). Acupuncture will be executed with size 0.30×40mm needle. EA will be performed with electronic acupuncture instruments

Device: electroacupunctureBehavioral: Rehabilitation Training

rehabilitation training only

ACTIVE COMPARATOR

The rehabilitation group will be only treated with the Otago exercise program(OEP). The Otago Exercise is a program developed by the research group of fall prevention in the elderly led by Campbell of Otago Medical University in the 1990s. It is a home exercise program aimed at strengthening lower extremity muscle, balance and preventing falls in the elderly. Otago Exercise combines resistance exercise, balance training and aerobic walking and is an exercise prescription for elderly patients with sarcopenia (details are as follows).

Behavioral: Rehabilitation Training

Interventions

The rehabilitation training group will be only treated with the Otago exercise program(OEP). Otago Exercise combines resistance exercise, balance training and aerobic walking and is an exercise prescription for elderly patients with sarcopenia. 1. Exercise: including warm-up exercise (5 minutes) + resistance exercise (20 minutes) + balance training (5 minutes). Training intensity: 30 minutes a day, 3 times a week, once every other day, 12 weeks of training period; resistance exercise gradually increases the load. 2. Walking program: Take a walk. Activity intensity: 30 minutes each time, 2 times a week, combined with exercise (walking during the interval between exercise sessions), 12 weeks of training period

electroacupuncture and rehabilitation trainingrehabilitation training only

Participants are required to be in the supine position. Routine disinfection first. Participants are then subjected to acupuncture and achieve deqi sensation at all acupuncture points. Four paired of acupuncture points (i.e. Biguan acupoints and Futu points; Yanglingquan acupoints and Zusanli acupoints, identical on both sides) are connected to the EA devices. EA parameter is set as sparse wave and frequency is 2Hz. The intensity of the EA is determined by the patients' tolerance. Needles will be left in place and each session of EA will last 30 minutes. Participants will undergo a total of 36 EA sessions, with the frequency of 3 sessions every week for 12 weeks.

electroacupuncture and rehabilitation training

Eligibility Criteria

Age60 Years - 95 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • years ≤ age ≤ 95 years, male or female;
  • Patients are able to walk and communicate independently, and can complete required rehabilitation training;
  • Patients meet the diagnostic criteria proposed by the Asian Working Group for Sarcopenia(AWGS);
  • Patients volunteer to participate in this study and sign the informed consent.

You may not qualify if:

  • Patients with serious primary diseases of heart, brain, liver, kidney and hematopoietic system;
  • Patients with severe mental illness, cognitive impairment, and disorientation;
  • Patients have trauma and unsuitable for sports;
  • Patients with electronic devices or metal objects implanted in the body;
  • Patients can't complete the required rehabilitation training;
  • Patients cannot receive EA treatment due to any reasons
  • Patients are participating in other drugs, acupuncture and massage trials.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Third Affiliated Hospital of Zhejiang Chinese Medical University

Hangzhou, Zhejiang, China

RECRUITING

Related Publications (1)

  • Wu W, Huang X, Fang L, Hu H, Han D. Electroacupuncture Plus Exercise for Sarcopenia in Older Adults: Protocol for a Randomized, Controlled, Assessor-Blinded Trial. Clin Interv Aging. 2025 Oct 23;20:1775-1786. doi: 10.2147/CIA.S545035. eCollection 2025.

MeSH Terms

Conditions

Sarcopenia

Interventions

Electroacupuncture

Condition Hierarchy (Ancestors)

Muscular AtrophyNeuromuscular ManifestationsNeurologic ManifestationsNervous System DiseasesAtrophyPathological Conditions, AnatomicalPathological Conditions, Signs and SymptomsSigns and Symptoms

Intervention Hierarchy (Ancestors)

Combined Modality TherapyTherapeuticsAcupuncture TherapyComplementary TherapiesElectric Stimulation TherapyPhysical Therapy ModalitiesRehabilitationTranscutaneous Electric Nerve StimulationAnalgesiaAnesthesia and AnalgesiaAnesthesia

Study Officials

  • Wenzhe Wu, Master

    The Third Affiliated hospital of Zhejiang Chinese Medical University

    STUDY DIRECTOR
  • Ming Guo, Doctor

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    PRINCIPAL INVESTIGATOR
  • Hantong Hu, Doctor

    The Third Affiliated hospital of Zhejiang Chinese Medical University

    PRINCIPAL INVESTIGATOR
  • Hong Gao, Master

    The Third Affiliated hospital of Zhejiang Chinese Medical University

    PRINCIPAL INVESTIGATOR
  • Jinkuo Pang, Bachelor

    The Third Affiliated hospital of Zhejiang Chinese Medical University

    PRINCIPAL INVESTIGATOR
  • Yanfei Cao, Master

    The Third Affiliated hospital of Zhejiang Chinese Medical University

    PRINCIPAL INVESTIGATOR
  • Yiting Zhang, Master

    The Third Affiliated hospital of Zhejiang Chinese Medical University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Wenzhe Wu, Master

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Attending Physician

Study Record Dates

First Submitted

June 12, 2022

First Posted

June 24, 2022

Study Start

July 2, 2022

Primary Completion

December 31, 2025

Study Completion (Estimated)

December 31, 2026

Last Updated

February 24, 2026

Record last verified: 2026-02

Data Sharing

IPD Sharing
Will not share

no plan

Locations